靶向昼夜节律时钟破坏胶质母细胞瘤干细胞
该研究探讨胶质母细胞瘤干细胞(GSC)对核心时钟转录因子BMAL1和CLOCK的依赖性。结果显示GSC、分化胶质瘤细胞和非恶性脑培养物均显示稳健昼夜节律,但仅GSC对BMAL1和CLOCK有高度依赖以维持最佳生长。敲低BMAL1或CLOCK诱导GSC细胞周期阻滞和凋亡,且BMAL1优先结合代谢基因和活跃染色质区域。靶向BMAL1或CLOCK减弱线粒体代谢功能并降低三羧酸循环酶表达。Cryptochrome和REV-ERB激动剂下调干细胞因子并减少GSC生长,联合使用产生协同抗肿瘤效果。
要点
- GSC选择性依赖核心时钟转录因子BMAL1和CLOCK维持生长。
- 靶向BMAL1或CLOCK诱导GSC细胞周期阻滞和凋亡并减弱线粒体代谢。
- Cryptochrome与REV-ERB激动剂联合产生协同抗肿瘤效果。
核心结论
- GSC利用昼夜节律调节因子超越经典节律回路以促进干性维持和代谢,提供新的治疗范式。
研究设计与样本
- 研究比较了GSC、分化胶质瘤细胞(DGC)和非恶性脑培养物的昼夜节律及对BMAL1/CLOCK的依赖性。
主要发现
- GSC、DGC和非恶性脑培养物均显示稳健昼夜节律,但仅GSC对BMAL1和CLOCK高度依赖以维持最佳生长。
- 敲低BMAL1或CLOCK诱导GSC细胞周期阻滞和凋亡。
- 染色质免疫沉淀显示BMAL1在GSC中优先结合代谢基因并关联活跃染色质区域,相较于神经干细胞。
- 靶向BMAL1或CLOCK减弱线粒体代谢功能并降低三羧酸循环酶表达。
- Cryptochrome和REV-ERB激动剂下调干细胞因子、减少GSC生长,联合使用产生协同抗肿瘤效果。
临床怎么用
- 药理学靶向昼夜节律网络可特异性破坏癌症干细胞生长和自我更新。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Glioblastomas are highly lethal cancers, containing self-renewing glioblastoma stem cells (GSC). Here, we show that GSCs, differentiated glioblastoma cells (DGC), and nonmalignant brain cultures all displayed robust circadian rhythms, yet GSCs alone displayed exquisite dependence on core clock transcription factors, BMAL1 and CLOCK, for optimal cell growth. Downregulation of BMAL1 or CLOCK in GSCs induced cell-cycle arrest and apoptosis. Chromatin immunoprecipitation revealed that BMAL1 preferentially bound metabolic genes and was associated with active chromatin regions in GSCs compared with neural stem cells. Targeting BMAL1 or CLOCK attenuated mitochondrial metabolic function and reduced expression of tricarboxylic acid cycle enzymes. Small-molecule agonists of two independent BMAL1-CLOCK negative regulators, the cryptochromes and REV-ERBs, downregulated stem cell factors and reduced GSC growth. Combination of cryptochrome and REV-ERB agonists induced synergistic antitumor efficacy. Collectively, these findings show that GSCs co-opt circadian regulators beyond canonical circadian circuitry to promote stemness maintenance and metabolism, offering novel therapeutic paradigms. SIGNIFICANCE: Cancer stem cells are highly malignant tumor-cell populations. We demonstrate that GSCs selectively depend on circadian regulators, with increased binding of the regulators in active chromatin regions promoting tumor metabolism. Supporting clinical relevance, pharmacologic targeting of circadian networks specifically disrupted cancer stem cell growth and self-renewal.This article is highlighted in the In This Issue feature, p. 1469.
引用
- Dong Z, Zhang G, Qu M, et al. Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock. Cancer Discov. 2019. PMID: 31455674. doi:10.1158/2159-8290.CD-19-0215
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。